Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.081 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |